Company Presentation
Ciloa SAS
| Country: | France |
| Category: | Advanced Biotech Company |
| Room: | Osaka |
| Date: | 23.04.2024. |
| Time: | 16:00 – 16:15 |
| Website: | www.ciloa.fr |
| Speaker: | Robert Z. MAMOUN, CEO, co-Founder |
Company profile
A BIOTHERAPEUTIC CO-AGONIST THAT ENHANCES THE EFFECTS OF GLP-1R AGONIST ON OBESITY AND DIABETES.
Ciloa, a pioneer in in vivo exosome bioengineering, has stabilized highly multimerized and functional adiponectin by anchoring it on exosomes. Pairing these adiponectin-exosomes with a GLP-1R agonist boosts weight loss, improves fat elimination in all organs tested, and induces a net increase in insulin sensitivity, while preserving muscle mass.
